N/A
N=906
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Glaucoma · Glaucoma Suspect · Diabetic Retinopathy · Ocular Hypertension · Cataract
Bottom Line
View on ClinicalTrials.gov: NCT02390245 ↗Enrolled (actual)
906
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Fundus Camera Images Via Telemedicine — 355; 384; 167 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Free Eye Screenings (Other); Enhanced Intervention (Other); Usual Care (Other)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- Wills Eye
- Primary completion
- Sep 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fundus Camera Images Via Telemedicine |
355; 384; 167 | — |
| PRIMARY Intraocular Pressure |
10; 3; 2; 728; 163 | — |
| PRIMARY Diagnostic Image Confirmation by Ophthalmologist |
38; 159; 25; 23; 15; 84 | — |
| SECONDARY Adherence to Follow-up Ophthalmic Care. |
128; 67; 32; 14; 97; 39 | — |
Summary
The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.
Eligibility Criteria
Inclusion Criteria
- African-American, Hispanic, or Asian individuals over age 40
- Caucasian individuals over age 65
- Individuals of any ethnicity, over age 40 with a family history of glaucoma
- Individuals of any ethnicity, over age 40 with diabetes
- Individuals who meet one of the above criteria who have not seen an ophthalmologist in the past year
Exclusion Criteria
Any patient with previously diagnosed glaucoma, glaucoma suspect, or eye diseases who is currently being followed by an ophthalmologist
-
Data sourced from ClinicalTrials.gov (NCT02390245). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.